Difficulty: Medium
Average Score: 71%
Practice
The mechanism by which sulfasalazine exerts its primary action in ulcerative colitis is inhibition of
Correct answer
B
Rationale
In the context of chemotherapy drugs, understanding the mechanism of action of each drug is crucial for effective treatment. Sulfasalazine is commonly used in the treatment of ulcerative colitis. The correct answer to the question is B) The formation of leukotrienes and prostaglandins.
Sulfasalazine works by inhibiting the formation of leukotrienes and prostaglandins, which are inflammatory mediators involved in the pathogenesis of ulcerative colitis. By blocking the synthesis of these inflammatory molecules, sulfasalazine helps to reduce inflammation in the gut mucosa, thereby alleviating symptoms of ulcerative colitis.
Option A) Folic acid synthesis is not the primary mechanism of action of sulfasalazine in ulcerative colitis. While sulfasalazine does interfere with folic acid absorption, this is not its main therapeutic effect in treating ulcerative colitis.
Option C) Phospholipase C is not the target of sulfasalazine in ulcerative colitis. Phospholipase C is involved in cell signaling pathways but is not directly affected by sulfasalazine.
Option D) Proton pump activity is not the primary target of sulfasalazine in ulcerative colitis. Proton pump inhibitors are a different class of drugs used to reduce stomach acid production in conditions like GERD and ulcers.
Understanding the specific mechanisms of action of chemotherapy drugs like sulfasalazine is essential for healthcare providers to make informed treatment decisions and optimize patient outcomes. It also highlights the importance of personalized medicine in selecting the most appropriate therapy for individual patients based on the underlying pathophysiology of their condition.
Sulfasalazine works by inhibiting the formation of leukotrienes and prostaglandins, which are inflammatory mediators involved in the pathogenesis of ulcerative colitis. By blocking the synthesis of these inflammatory molecules, sulfasalazine helps to reduce inflammation in the gut mucosa, thereby alleviating symptoms of ulcerative colitis.
Option A) Folic acid synthesis is not the primary mechanism of action of sulfasalazine in ulcerative colitis. While sulfasalazine does interfere with folic acid absorption, this is not its main therapeutic effect in treating ulcerative colitis.
Option C) Phospholipase C is not the target of sulfasalazine in ulcerative colitis. Phospholipase C is involved in cell signaling pathways but is not directly affected by sulfasalazine.
Option D) Proton pump activity is not the primary target of sulfasalazine in ulcerative colitis. Proton pump inhibitors are a different class of drugs used to reduce stomach acid production in conditions like GERD and ulcers.
Understanding the specific mechanisms of action of chemotherapy drugs like sulfasalazine is essential for healthcare providers to make informed treatment decisions and optimize patient outcomes. It also highlights the importance of personalized medicine in selecting the most appropriate therapy for individual patients based on the underlying pathophysiology of their condition.